Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ali Ajam
Response To: “A Somatization Comorbidity Phenotype Impacts Response to Therapy in Rheumatoid Arthritis: Post Hoc Results From the Certolizumab Pegol Phase 4 PREDICT Trial”
Arthritis Research & Therapy
Related publications
Efficacy and Safety of Bimekizumab as Add-On Therapy for Rheumatoid Arthritis in Patients With Inadequate Response to Certolizumab Pegol: A Proof-Of-Concept Study
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
SAT0468 Presence of Poor Prognostic Factors May Predict Response to Abatacept in Patients With Active Psoriatic Arthritis: Results From a Post Hoc Analysis From a Phase Iii Study
Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis in Romania
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pms77 - Decline in Healthcare Resource Consumption for Patients With Rheumatoid Arthritis Starting Certolizumab Pegol Therapy in France (The Eclair Study)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Randomised Clinical Trial: Certolizumab Pegol for Fistulas in Crohn’s Disease - Subgroup Results From a Placebo-Controlled Study
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Synovial Tissue Response to Treatment in Rheumatoid Arthritis
Open Rheumatology Journal
Rheumatology
Development and Validation of a Prognostic Multivariable Model to Predict Insufficient Clinical Response to Methotrexate in Rheumatoid Arthritis
PLoS ONE
Multidisciplinary
Remarkably Similar Response to Gold Therapy in HLA Identical Sibs With Rheumatoid Arthritis.
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
The Efficacy of Certolizumab Pegol Re-Treatment on Plaque Psoriasis Following a Blinded Treatment Break: Results From the CIMPACT Trial
SKIN The Journal of Cutaneous Medicine
